These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35339508)

  • 1. Novel antitumor activity of the combined treatment of galloylquinic acid compounds with doxorubicin in solid Ehrlich carcinoma model via the Notch signaling pathway modulation.
    Abd El-Salam MA; El-Tanbouly GS; Bastos JK; Metwaly HA
    Life Sci; 2022 Jun; 299():120497. PubMed ID: 35339508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diallyl trisulfide potentiates chemotherapeutic efficacy of doxorubicin in experimentally induced mammary carcinoma: Role of Notch signaling.
    Elsherbiny NM; El-Sherbiny M; Zaitone SA
    Pathol Res Pract; 2020 Oct; 216(10):153139. PubMed ID: 32853959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of VEGF and inflammatory cytokines, modulation of Annexin A1 and organ functions by galloylquinic acids in breast cancer model.
    Abd El-Salam M; El-Tanbouly G; Bastos J; Metwaly H
    Sci Rep; 2023 Jul; 13(1):12268. PubMed ID: 37507468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin augments doxorubicin cytotoxicity in mammary carcinoma through activation of adenosine monophosphate protein kinase pathway.
    El-Ashmawy NE; Khedr NF; El-Bahrawy HA; Abo Mansour HE
    Tumour Biol; 2017 May; 39(5):1010428317692235. PubMed ID: 28459206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginger extract adjuvant to doxorubicin in mammary carcinoma: study of some molecular mechanisms.
    El-Ashmawy NE; Khedr NF; El-Bahrawy HA; Abo Mansour HE
    Eur J Nutr; 2018 Apr; 57(3):981-989. PubMed ID: 28229277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fruticuline A, a chemically-defined diterpene, exerts antineoplastic effects in vitro and in vivo by multiple mechanisms.
    Corso CR; Stipp MC; Radulski DR; Mariott M; da Silva LM; de Souza Ramos EA; Klassen G; Queiroz Telles JE; Oliveira CS; Stefanello MÉA; Verhoeven AJ; Oude Elferink RPJ; Acco A
    Sci Rep; 2020 Oct; 10(1):16477. PubMed ID: 33020521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursolic acid inhibits tumor angiogenesis and induces apoptosis through mitochondrial-dependent pathway in Ehrlich ascites carcinoma tumor.
    Saraswati S; Agrawal SS; Alhaider AA
    Chem Biol Interact; 2013 Nov; 206(2):153-65. PubMed ID: 24051192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of sitagliptin and vitamin B12 on Ehrlich ascites carcinoma solid tumor in mice.
    Salah R; Salama MF; Mahgoub HA; El-Sherbini ES
    J Biochem Mol Toxicol; 2021 Feb; 35(2):e22645. PubMed ID: 33016524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hesperidin on mice bearing Ehrlich solid carcinoma maintained on doxorubicin.
    Khedr NF; Khalil RM
    Tumour Biol; 2015 Dec; 36(12):9267-75. PubMed ID: 26099723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
    Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
    Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvia lachnostachys Benth has antitumor and chemopreventive effects against solid Ehrlich carcinoma.
    Corso CR; Stipp MC; Adami ER; da Silva LM; Mariott M; de Andrade SF; de Souza Ramos EA; Klassen G; Beltrame OC; Queiroz-Telles JE; de Oliveira CS; Stefanello MÉA; Acco A
    Mol Biol Rep; 2019 Oct; 46(5):4827-4841. PubMed ID: 31270760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic efficacy of γ-radiation together with gallium trichloride and/or doxorubicin against Ehrlich carcinoma in female mice.
    Kandil E; Aziz NA
    Tumour Biol; 2016 Feb; 37(2):1825-34. PubMed ID: 26318299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential therapy of vitamin B17 against Ehrlich solid tumor induced changes in Interferon gamma, Nuclear factor kappa B, DNA fragmentation, p53, Bcl2, survivin, VEGF and TNF-α Expressions in mice.
    El-Masry T; Al-Shaalan N; Tousson E; Buabeid M; Al-Ghadeer A
    Pak J Pharm Sci; 2020 Jan; 33(1(Supplementary)):393-401. PubMed ID: 32122873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the anticancer effects of
    Alotaibi BS; El-Masry TA; Selim H; El-Bouseary MM; El-Sheekh MM; Makhlof MEM; El-Nagar MMF
    Front Pharmacol; 2024; 15():1345516. PubMed ID: 38469406
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytotoxic and antitumor effects of brucine on Ehrlich ascites tumor and human cancer cell line.
    Agrawal SS; Saraswati S; Mathur R; Pandey M
    Life Sci; 2011 Aug; 89(5-6):147-58. PubMed ID: 21684292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymoquinone and pentoxifylline enhance the chemotherapeutic effect of cisplatin by targeting Notch signaling pathway in mice.
    Mosalam EM; Zidan AA; Mehanna ET; Mesbah NM; Abo-Elmatty DM
    Life Sci; 2020 Mar; 244():117299. PubMed ID: 31953157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol improves the anticancer effects of doxorubicin in vitro and in vivo models: A mechanistic insight.
    Rai G; Mishra S; Suman S; Shukla Y
    Phytomedicine; 2016 Mar; 23(3):233-42. PubMed ID: 26969377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual targeting of Notch and Wnt/β-catenin pathways: Potential approach in triple-negative breast cancer treatment.
    Nasser F; Moussa N; Helmy MW; Haroun M
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Mar; 394(3):481-490. PubMed ID: 33052427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of Noscapine in combination with Doxorubicin in triple negative breast cancer.
    Chougule MB; Patel AR; Jackson T; Singh M
    PLoS One; 2011 Mar; 6(3):e17733. PubMed ID: 21423660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin sensitizes cancer cells to Smac mimetic via synergistic activation of the CYLD/RIPK1/FADD/caspase-8-dependent apoptosis.
    Yang C; Ran Q; Zhou Y; Liu S; Zhao C; Yu X; Zhu F; Ji Y; Du Q; Yang T; Zhang W; He S
    Apoptosis; 2020 Jun; 25(5-6):441-455. PubMed ID: 32418059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.